[S-40] Symposium 40 Dyskinesia in Parkinson's Disease: Filling the Bedside-to-Bench Gap

[S-40-1] Update on the Clinical Phenomenology, Risk Factors and Burden of Dyskinesias

^○Atsushi Takeda^1,2 (1.Department of Neurology, National Hospital Organization Sendai-Nishitaga Hospital, Japan, 2.Department of motor and cognitive aging, Tohoku university graduate school of medicine, Japan)

Atsushi Takeda
Director, National Hospital Organization, Sendai-Nishitaga Hospital

Dr. Takeda MD, PhD, is a Director of National Hospital Organization, Sendai-Nishitaga Hospital and a visiting Professor in the department of Cognitive & Motor Aging in Tohoku University, Graduate School of Medicine. He received his MD (1985) and PhD degrees (1992) from Tohoku University. His special interests are focused on pathophysiological mechanisms of cognitive and movement impairments in the synucleinopathies. He organized a multicenter- randomized double-blinded clinical trial of donepezil on Parkinson disease with severe hyposmia (Granted by AMED). He is currently also a vice chairman of the Ad Hoc committee for the Japanese clinical practice guidelines of Parkinson disease.